Preisverleihung Zell am See bei dem Kongress:
Radioactive Isotopes in Molecular Imaging & Therapy, 33rd International Austrian Winter Symposium & 13th Alpe Adria Nuclear Medicine, Joint Meeting, January 24th-27th 2018
1., 2. & 3. Platz des Allgemeinen Förderungspreises Nuklearmedizin (2017) OGNMB an die Univ.-Klinik für Nuklearmedizin Innsbruck:
Publikationen:
1.„68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour”. Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D, Scarpa L, di Santo G, Roig LG, Maffey-Steffan J, Horninger W, Virgolini IJ. Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):941-949.
2.“Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.” Uprimny C, Kroiss AS, Decristoforo C, Fritz J, Warwitz B, Scarpa L, Roig LG, Kendler D, von Guggenberg E, Bektic J, Horninger W, Virgolini IJ. Eur J Nucl Med Mol Imaging. 2017 May;44(5):765-775.
3.„Early PET imaging with 68Ga-PSMA-11 increases the detection rate of local recurrence in prostate cancer patients with biochemical recurrence.” Uprimny C, Kroiss AS, Fritz J, Decristoforo C, Kendler D, von Guggenberg E, Nilica B, Maffey-Steffan J, di Santo G, Bektic J, Horninger W, Virgolini IJ. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1647-1655.
